Insight Molecular Diagnostics Inc. cotiza a 2.99 USD y tiene una capitalización bursátil de $98M. En los últimos 12 meses ha facturado $2M con un margen de flujo de caja libre del -625.6%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.24 | $-0.12 | $-0.72 |
| Estimado | $-0.22 | $-0.23 | $-0.26 | $-0.24 |
| Sorpresa | — | -4.3% | +53.8% | -200.0% |
| Métrica | IMDX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 56.7% | 57.0% | -0.4% |
| Operating Margin | -1260.8% | -38.6% | -1222.1% |
| Net Margin | -1238.5% | -33.6% | -1205.0% |
| FCF Margin | -625.6% | -13.9% | -611.8% |
| ROE | — | -40.4% | — |
| ROA | -195.0% | -32.0% | -163.0% |
| Current Ratio | 1.27 | 2.84 | -1.57 |
| Debt / Equity | — | 0.28 | — |